JP2023513847A5 - - Google Patents
Info
- Publication number
- JP2023513847A5 JP2023513847A5 JP2022549737A JP2022549737A JP2023513847A5 JP 2023513847 A5 JP2023513847 A5 JP 2023513847A5 JP 2022549737 A JP2022549737 A JP 2022549737A JP 2022549737 A JP2022549737 A JP 2022549737A JP 2023513847 A5 JP2023513847 A5 JP 2023513847A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- point
- score
- reduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900472 | 2020-02-19 | ||
| AU2020900472A AU2020900472A0 (en) | 2020-02-19 | Method for treating chronic graft versus host disease | |
| PCT/EP2021/054066 WO2021165420A1 (en) | 2020-02-19 | 2021-02-18 | Method for treating chronic graft versus host disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513847A JP2023513847A (ja) | 2023-04-03 |
| JP2023513847A5 true JP2023513847A5 (https=) | 2024-02-29 |
Family
ID=74701467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549737A Pending JP2023513847A (ja) | 2020-02-19 | 2021-02-18 | 慢性移植片対宿主病の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230097931A1 (https=) |
| EP (1) | EP4106776A1 (https=) |
| JP (1) | JP2023513847A (https=) |
| KR (1) | KR20220143092A (https=) |
| CN (1) | CN115361960A (https=) |
| AU (1) | AU2021222342A1 (https=) |
| BR (1) | BR112022016448A2 (https=) |
| CA (1) | CA3168330A1 (https=) |
| WO (1) | WO2021165420A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070258963A1 (en) | 2006-01-13 | 2007-11-08 | Osiris Therapeutics, Inc. | Mesenchymal stem cells expressing TNF-alpha receptors |
| US20120087868A1 (en) | 2010-10-08 | 2012-04-12 | Gabriele Todd | Nanoparticle-loaded cells |
| SG11202004680UA (en) | 2017-11-22 | 2020-06-29 | Mesoblast Int Sarl | Cellular compositions and methods of treatment i |
| WO2024168161A1 (en) * | 2023-02-08 | 2024-08-15 | Mesoblast International Sarl | Potency assay and manufacturing method |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US6251295B1 (en) | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
| KR20080105555A (ko) * | 2007-05-31 | 2008-12-04 | 인하대학교 산학협력단 | 중간엽 골수세포를 이용한 이식편대숙주질환 치료제 및치료방법 |
| EP1795588A1 (en) * | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| EP2324109B1 (en) * | 2008-09-03 | 2016-10-26 | Mesoblast, Inc. | Expansion of haemopoietic precursors |
| US20120087868A1 (en) * | 2010-10-08 | 2012-04-12 | Gabriele Todd | Nanoparticle-loaded cells |
| ES2984009T3 (es) * | 2013-11-04 | 2024-10-28 | Isopogen Pty Ltd | Método de cultivo celular |
| SG11201909856XA (en) * | 2017-05-04 | 2019-11-28 | Mesoblast Int Sarl | Mesenchymal lineage precursor or stem cells with enhanced immunosuppression |
-
2021
- 2021-02-18 KR KR1020227032165A patent/KR20220143092A/ko active Pending
- 2021-02-18 US US17/904,581 patent/US20230097931A1/en active Pending
- 2021-02-18 CA CA3168330A patent/CA3168330A1/en active Pending
- 2021-02-18 JP JP2022549737A patent/JP2023513847A/ja active Pending
- 2021-02-18 BR BR112022016448A patent/BR112022016448A2/pt unknown
- 2021-02-18 WO PCT/EP2021/054066 patent/WO2021165420A1/en not_active Ceased
- 2021-02-18 CN CN202180027192.3A patent/CN115361960A/zh active Pending
- 2021-02-18 EP EP21707636.3A patent/EP4106776A1/en active Pending
- 2021-02-18 AU AU2021222342A patent/AU2021222342A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513847A5 (https=) | ||
| CN104884076B (zh) | 利用了hmgb1片段的心肌梗塞的治疗方法 | |
| US20120171161A1 (en) | Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof | |
| Fujio et al. | Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursors | |
| Novotny et al. | Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFkB | |
| KR20180016720A (ko) | 지방 유래 줄기세포로부터 추출된 엑소좀을 유효성분으로 포함하는 폐 섬유증 예방 또는 치료용 조성물 | |
| CN113633663A (zh) | 诱导性多能干细胞分化来源的epc在制备脑卒中治疗剂中的应用 | |
| Galipeau | Mesenchymal stromal cells for graft-versus-host disease: a trilogy | |
| KR102088767B1 (ko) | 혼합물 4f를 이용한 줄기세포 생물학적 활성 증가용 조성물 | |
| RU2368384C2 (ru) | Биотрансплантат, способ лечения хронических заболеваний печени и способ лечения цирроза печени и портальной гипертензии | |
| CN110462023A (zh) | 作为有效成分包括组蛋白去乙酰化酶抑制剂和激活因子的干细胞活性促进用组合物 | |
| CN115361959A (zh) | 用于使用间充质谱系前体或干细胞治疗过度炎症的方法 | |
| JP2023512843A5 (https=) | ||
| JP7045670B2 (ja) | 多能性幹細胞による虚血再灌流肺障害の軽減及び治療 | |
| JP2023517035A5 (https=) | ||
| JP2023517636A (ja) | 炎症性腸疾患を治療するための方法ｉ | |
| McCully et al. | Therapeutic mitochondrial transplantation | |
| KR20200061242A (ko) | Nadph 산화제의 억제를 통한 기능 강화 중간엽 줄기세포의 용도 | |
| JP4232866B2 (ja) | 細胞障害抑制剤 | |
| JP5602364B2 (ja) | 幹細胞及び／又は前駆細胞の賦活剤 | |
| WO2023217247A1 (zh) | Cd177抑炎型中性粒细胞对缺血性脑卒中治疗的应用 | |
| US12569460B2 (en) | Application of thyroid hormones and thyroid hormone analogues to preparation of drugs for treating sickle-cell disease | |
| WO2023098088A1 (zh) | 外泌体在胸主动脉夹层/动脉瘤中的作用 | |
| US20210338713A1 (en) | Reduction of Pulmonary Inflammation Using Therapeutic Gas Mixtures | |
| JP7102666B2 (ja) | Ｍｕｓｅ細胞動員剤及び心筋障害への利用 |